Physician profile
Richard Blansky
NPI 1790725778
$1,157.01
in general payments reported to CMS, 2019-2025
16 companies · $21.01 in 2025
The $21.01 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $909 · 2021: $19.05 · 2022: $121 · 2023: $49.66 · 2024: $37.99 · 2025: $21.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $88.66 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $88.66 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $224.42 | 2019-2023 | Skyrizi, Rinvoq |
| Janssen Biotech, INC. | $141.38 | 2019-2025 | Tremfya |
| Pfizer INC. | $127.78 | 2019 | |
| Boston Scientific Corporation | $119.00 | 2019 | |
| Medical Device Business Services, INC. | $108.67 | 2019 | |
| Gilead Sciences, INC. | $76.62 | 2019 | |
| Braintree Laboratories, INC. | $59.68 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $53.05 | 2019 | |
| Merck Sharp & Dohme LLC | $49.34 | 2019-2024 | Bridion |
| Intercept Pharmaceuticals, INC. | $40.65 | 2019 | |
| Janssen Scientific Affairs, LLC | $36.26 | 2019 | |
| Allergan, INC. | $35.49 | 2019 | |
| Qol Medical, LLC | $28.75 | 2019 | |
| Glaxosmithkline, LLC. | $22.54 | 2023 | Jemperli, Zejula |
| Csl Behring | $20.00 | 2024 | Kcentra |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Concordia Pharmaceuticals INC. | $13.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Blansky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.